Acta Scientific Clinical Case Reports

Case ReportVolume 3 Issue 5

Double Trouble: Cushing's Syndrome Due to ACTH-secreting Pheochromocytoma

Niladri Das, Soumik Goswami, Arjun Baidya, Nilanjan Sengupta, Prashant Gaikwad, Deep Hathi and Silima S Tarenia*

Department of Endocrinology, Nilratan Sircar Medical College and Hospital, Kolkata, India

*Corresponding Author: Silima S Tarenia, Department of Endocrinology, Nilratan Sircar Medical College and Hospital, Kolkata, India.

Received: March 29, 2022; Published: April 20, 2022

Abstract

Pheochromocytoma is a catecholamine secreting adrenal tumor originating from chromaffin cells which accounts for 5% of ectopic ACTH syndrome cases and is infrequently reported in medical literature.

Case Description: A 36 year old woman presented with Cushingoid habitus, resistant hypertension, hypokalemia and recent onset diabetes. Endocrinological examination revealed ectopic ACTH production with hypercortisolemia and elevated plasma catecholamines. MRI abdomen showed a large left sided adrenal tumor. After initial medical management, left adrenalectomy resulted in complete remission of Cushing’s syndrome and pheochromocytoma.

Conclusion: We present here a case of ACTH producing pheochromocytoma with clinical features of Cushing syndrome.

Keywords: Pheochromocytoma; Ectopic ACTH Syndrome; Cushing’s Syndrome

Bibliography

  1. J Lindholm., et al. “Incidence and late prognosis of Cushing’s syndrome: a population-based study”. The Journal of Clinical Endocrinology and Metabolism 1 (2001): 117-123.
  2. AM Isidori., et al. “The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management and long-term follow-up”. The Journal of Clinical Endocrinology and Metabolism 2 (2006): 371-377.
  3. H Chen., et al. “Adrenocorticotropic hormone-secreting pheochromocytomas: The exception to the rule”. Surgery6 (1995): 988-995.
  4. L Crapo. “Cushing’s syndrome: a review of diagnostic tests”. Metabolism9 (1979): 955-977.
  5. I Ilias., et al. “Cushing’s syndrome due to ectopic corticotropin secretion: 20 years’ experience at the National Institute of Health”. The Journal of Clinical Endocrinology and Metabolism 8 (2005): 4955-4962.
  6. Mark E Molith. “Non functioning pituitary tumours and pituitary incidentalomas”. Endocrinology and Metabolism Clinics of North America 1 (2008): 151-71,xi.
  7. Ollivier M., et al. “Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?” European Journal of Endocrinology 5 (2018): L1-L2.
  8. Young J., et al. “Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France”. European Journal of Endocrinology 5 (2018): 447-458.
  9. TIM Korevaar and AB Grossman. “Pheochromocytomas and paragangliomas: assessment of malignant potential”. Endocrine3 (2011): 354-365.

Citation: Niladri Das., et al. “Double Trouble: Cushing's Syndrome Due to ACTH-secreting Pheochromocytoma". Acta Scientific Clinical Case Reports 3.5 (2022): 72-75.

Copyright: © 2022 Niladri Das., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 20, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US